Physician
Rheumatology
Dr. Gary M. Kammer, MD
|
|
Give Review
Gary Kammer works in the field of Rheumatology. He attended The Ohio State University College of Medicine. He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACR)" and "Fellow". Doctor Gary M. Kammer, MD is a published doctor and has 85 publications published. The lastest was: 'Emerging concepts of the molecular basis for estrogen effects on T lymphocytes in systemic lupus erythematosus.' He is registered with Medicare and accepts Medicare payments.
Publications
- Isolated necrotizing myopathy associated with ANTI-PL12 antibody.
- Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
- Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta.
- Mechanisms of deficient type I protein kinase A activity in lupus T lymphocytes.
- Protein kinase A and signal transduction in T lymphocytes: biochemical and molecular methods.
- Protein kinase A regulatory subunit type II beta directly interacts with and suppresses CREB transcriptional activity in activated T Cells.
- Treatment of primary Sjögren's Syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.
- Immunotherapy tackles lupus.
- Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction.
- Abnormal T Cell signal transduction in systemic lupus erythematosus.
- Transcript mutations of the alpha regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes.
- Study of HLA antigens in familial and sporadic rheumatoid Arthritis.
- [The many faces of breast cancer].
- [The alveolar soft tissue sarcoma (malignant Abrikosoff tumor)].
- [New aspects of the curative treatment of breast cancer].
- [Replacement plastic surgery in subcutaneous mastectomy].
- [New aspects in the curative treatment of breast cancer].
- [How safe is subcutaneous mastectomy for prevention of breast cancer? (author''s transl)].
- [On the malignity problem in gastrointestinal neurinomas].
- Extended haplotypes of chromosome 6 in adult rheumatoid Arthritis.
- [The surgical treatment of epicondylitis - follow-up of 100 operated elbows (author''s transl)].
- [Adjuvant chemotherapy and receptors from the viewpoint of the practitioner].
- [Mastectomy? Why now?].
- Abnormal B Cell signal transduction in systemic lupus erythematosus.
- Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid Arthritis.
- Accessory Cell requirement in the proliferative response of T lymphocytes to hemocyanin.
- Capping of the surface OKT3 binding molecule prevents the T-Cell proliferative response to antigens: evidence that this molecule conveys the activation signal.
- HLA-DR4 is not a requisite for autoimmunity to collagen in rheumatoid Arthritis.
- Impaired T Cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte.
- Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus.
- Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
- Regulation of human T lymphocyte surface antigen mobility by purinergic receptors.
- Scanning-beam electron microscopy of Mycoplasma pneumoniae.
- Acute bulbar muscle dysfunction and hyperthyroidism. A study of four cases and review of the literature.
- Psoriatic Arthritis: a clinical, immunologic and HLA study of 100 patients.
- Renal resistance to parathyroid hormone with hyperphosphatemic osteomalacia and osteitis fibrosa. A case report.
- Secretion of an articular cartilage proteoglycan-degrading enzyme activity by murine T lymphocytes in vitro.
- Cerebral angiography as a guide for therapy in isolated central nervous system vasculitis.
- Intact proteoglycan is a polyclonal activator of murine B-lymphocytes.
- Effect of anti-T Cell autoantibodies from systemic lupus erythematosus sera upon T lymphocyte functions.
- Characterization of the human T lymphocyte adenosine receptor: comparison of normal and systemic lupus erythematosus Cells.
- The ethics of human experimentation.
- Adenosine: emerging role as an immunomodifying agent.
- Role of adenylate cyclase in human T-lymphocyte surface antigen capping.
- Adenosine.
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the Immune response.
- Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway.
- Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway.
- Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by a cAMP-dependent pathway.
- Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes.
- UVB radiation and human monocyte accessory function: differential effects on pre-mitotic events in T-Cell activation.
- T lymphocyte Immune dysfunctions in systemic lupus erythematosus.
- cAMP-dependent protein kinase in chondrocyte cultures: holoenzyme activation, phosphorylation of Cellular proteins, effects of NSAIDs and possible role in proteoglycan...
- Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus.
- Human T lymphocyte cAMP-dependent protein kinase: subCellular distributions and activity ranges of type I and type II isozymes.
- Binding of circulating Immune complexes to human peripheral blood lymphocytes: effect of complement.
- Abnormal T lymphocyte signal transduction in systemic lupus erythematosus.
- T Cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T Cell receptor zeta chain ...
- Protein kinase A RI beta subunit deficiency in lupus T lymphocytes: bypassing a block in RI beta translation reconstitutes protein kinase A activity and augments IL-2 ...
- Fc epsilon receptor type I gamma chain replaces the deficient T Cell receptor zeta chain in T Cells of patients with systemic lupus erythematosus.
- Polymorphisms/mutations of TCR-zeta-chain promoter and 3'' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3'' untranslate...
- Molecular basis of deficient IL-2 production in T Cells from patients with systemic lupus erythematosus.
- Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T Cells.
- Molecular aberrations in human systemic lupus erythematosus.
- mRNA mutations of type I protein kinase A regulatory subunit alpha in T lymphocytes of a subject with systemic lupus erythematosus.
- Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes.
- Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
- High prevalence of T Cell type I protein kinase A deficiency in systemic lupus erythematosus.
- Diminished levels of protein kinase A RI alpha and RI beta transcripts and proteins in systemic lupus erythematosus T lymphocytes.
- Emerging concepts of the molecular basis for estrogen effects on T lymphocytes in systemic lupus erythematosus.
- Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane.
- Clinical expression of autoimmune Diseases in older adults.
- Familial clustering of end-stage renal Disease in blacks with lupus nephritis.
- B Cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.
- Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes: II. Abnormal isozyme kinetics.
- The T Cell enigma in lupus.
- Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
- The effect of circulating serum factors from patients with systemic lupus erythematosus on protein kinase A (PKA) activity and PKA-dependent protein phosphorylation in...
- Early events of human T lymphocyte activation are associated with type I protein kinase A activity.
- Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.
- The effect of nonsteroidal anti-inflammatory drugs on cAMP-dependent protein kinase-mediated phosphorylation by human chondrocytes in culture.
- Immune complex assays in rheumatoid disorders.
- Circulating Immune complexes in patients with necrotizing vasculitis.
- Capping of human T Cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton.
Schools
Oh State Univ Coll Of Med and Pub Hlth
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
- View All
Conditions Treated
- Adhesive Capsulitis
- Ankylosing Spondylitis
- Antiphospholipid Syndrome (APS)
- Arthritis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Humana
- Medical Mutual of Ohio POS
- Medicare MCR
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACR)
- Fellow
Education
-
Johns Hopkins University -
The Ohio State University College of Medicine
Drug Facts
| NPI NUMBER | 1083685952 | |
| NPPES Provider LastName | KAMMER | |
| NPPES Provider FirstName | GARY | |
| NPPES Provider ZIPCode | 440948238 | |
| NPPES Provider State | OH | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 2041.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 175.0 | |
| Percent Opioid Claims | 8.57 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083685952 |
| Last Name Of The Provider | KAMMER |
| First Name Of The Provider | GARY |
| View All |
Similar Doctors
|
|
Dr. Jeffrey J. Wisnieski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice A. Granieri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
George E. Drogomir, PA-C |